NO20041291L - Medisinske preparater som inneholder angiotensin II-reseptorantagonist - Google Patents

Medisinske preparater som inneholder angiotensin II-reseptorantagonist

Info

Publication number
NO20041291L
NO20041291L NO20041291A NO20041291A NO20041291L NO 20041291 L NO20041291 L NO 20041291L NO 20041291 A NO20041291 A NO 20041291A NO 20041291 A NO20041291 A NO 20041291A NO 20041291 L NO20041291 L NO 20041291L
Authority
NO
Norway
Prior art keywords
receptor antagonist
preparations containing
medical preparations
containing angiotensin
angiotensin
Prior art date
Application number
NO20041291A
Other languages
English (en)
Other versions
NO20041291D0 (no
Inventor
Toshio Sada
Toshimori Inaba
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20041291D0 publication Critical patent/NO20041291D0/no
Publication of NO20041291L publication Critical patent/NO20041291L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Farmasøytisk preparat for administrering samtidig, separat eller sekvensielt av en angiotensin- II- reseptorantagonist og en ACAT-inhibitor.
NO20041291A 2001-08-28 2004-03-26 Medisinske preparater som inneholder angiotensin II-reseptorantagonist NO20041291L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001257435 2001-08-28
PCT/JP2002/008629 WO2003020315A1 (fr) 2001-08-28 2002-08-27 Compositions medicinales contenant un antagoniste du recepteur d'angiotensine ii

Publications (2)

Publication Number Publication Date
NO20041291D0 NO20041291D0 (no) 2004-03-26
NO20041291L true NO20041291L (no) 2004-05-27

Family

ID=19085097

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041291A NO20041291L (no) 2001-08-28 2004-03-26 Medisinske preparater som inneholder angiotensin II-reseptorantagonist

Country Status (17)

Country Link
US (1) US20040198788A1 (no)
EP (1) EP1421953A4 (no)
KR (1) KR20040032969A (no)
CN (1) CN1589154A (no)
AU (1) AU2002328569B9 (no)
BR (1) BR0212254A (no)
CA (1) CA2459017A1 (no)
CO (1) CO5560583A2 (no)
HU (1) HUP0401696A2 (no)
IL (1) IL160438A0 (no)
MX (1) MXPA04001878A (no)
NO (1) NO20041291L (no)
NZ (1) NZ531346A (no)
PL (1) PL368843A1 (no)
RU (1) RU2004105965A (no)
WO (1) WO2003020315A1 (no)
ZA (1) ZA200401603B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3045174A1 (en) * 2003-01-31 2016-07-20 Daiichi Sankyo Company, Limited Medicine for prevention of and treatment for arteriosclerosis and hypertension
WO2007086980A2 (en) * 2005-11-10 2007-08-02 Duke University Methods of determining the risk of developing coronary artery disease
KR101345876B1 (ko) * 2012-01-31 2013-12-30 인제대학교 산학협력단 피마사르탄을 함유하는 세포, 조직 또는 장기 보존용 조성물
CN112979617A (zh) * 2019-12-17 2021-06-18 中国科学院苏州纳米技术与纳米仿生研究所 一种厄贝沙坦哌嗪盐及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO170760C (no) * 1985-01-10 1992-12-02 Tanabe Seiyaku Co Analogifremgangsmaate for fremstilling av terapeutisk aktive nafthalenderivater
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US5120738A (en) * 1989-10-06 1992-06-09 Fujirebio Inc. Pantothenic acid derivatives
ATE134624T1 (de) * 1990-02-19 1996-03-15 Ciba Geigy Ag Acylverbindungen
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
GB9025509D0 (en) * 1990-11-23 1991-01-09 Fujisawa Pharmaceutical Co New amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
WO1992009572A1 (fr) * 1990-11-26 1992-06-11 Taisho Pharmaceutical Co., Ltd. Derive d'anilide
US5614519A (en) * 1991-02-06 1997-03-25 Karl Thomae Gmbh (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
FI112942B3 (fi) * 1991-02-21 2012-03-13 Daiichi Sankyo Co Ltd Menetelmä kohonneen verenpaineen hoitoon ja ennaltaehkäisyyn käyttökelpoisten 4'-(1H-imidatsol-1-yylimetyyli)-1,1' -bifenyylijohdannaisten valmistamiseksi
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
JP3720395B2 (ja) * 1994-09-20 2005-11-24 京都薬品工業株式会社 新規ヘテロ環誘導体、その製造方法およびその医薬用途
DE69617731T2 (de) * 1995-10-05 2002-08-08 Kyoto Pharmaceutical Industries, Ltd. Neue heterozyklische derivate und ihre medizinische anwendung
FR2741619B1 (fr) * 1995-11-28 1998-02-13 Pf Medicament Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique
CA2197364A1 (en) * 1996-02-15 1997-08-16 Toshikazu Suzuki Phenol compound and process for preparing the same
JPH11228416A (ja) * 1997-10-23 1999-08-24 Takeda Chem Ind Ltd 脂質低下剤
US6221897B1 (en) * 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DE19916108C1 (de) * 1999-04-09 2001-01-11 Aventis Pharma Gmbh Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
WO2002087580A1 (fr) * 2001-04-25 2002-11-07 Takeda Chemical Industries, Ltd. Promoteurs d'expression d'abc

Also Published As

Publication number Publication date
AU2002328569B9 (en) 2005-10-27
CO5560583A2 (es) 2005-09-30
US20040198788A1 (en) 2004-10-07
EP1421953A4 (en) 2004-09-15
RU2004105965A (ru) 2005-05-10
KR20040032969A (ko) 2004-04-17
EP1421953A1 (en) 2004-05-26
NZ531346A (en) 2005-10-28
WO2003020315A1 (fr) 2003-03-13
MXPA04001878A (es) 2004-06-15
CA2459017A1 (en) 2003-03-13
CN1589154A (zh) 2005-03-02
NO20041291D0 (no) 2004-03-26
PL368843A1 (en) 2005-04-04
AU2002328569B2 (en) 2005-09-22
ZA200401603B (en) 2004-10-19
IL160438A0 (en) 2004-07-25
HUP0401696A2 (hu) 2004-11-29
BR0212254A (pt) 2004-10-19

Similar Documents

Publication Publication Date Title
EE200300524A (et) Ühendid, mis on CB2-retseptori agonistid, neid sisaldavad ravimkoostised ja nimetatud ühendite kasutamine ravis
NO20052496D0 (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter.
CY1106468T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
DE50008336D1 (de) Mehrschichttablette zur verabreichung einer fixen kombination von tramadol und diclofenac
EA200501586A1 (ru) Фармацевтические продукты
BR0314356A (pt) Formulações de liberação retardada para administração oral de um agente terapêutico polipetìdeo e métodos utilizando as mesmas
DK1094816T3 (da) Biphenylsulfonamider som dobbelte angiotensin-endothelin-receptorantagonister
NO20053150D0 (no) System for administrasjon av medisin.
NO20015309L (no) 1- (P-tienylbenzyl)-imidazoler som anginotensin-(1-7) reseptoragonister, fremgangsmåte for fremstilling og anvendelse avde samme og farmasöytiske preparater som inneholder nevnteforbindelser
NO20052493D0 (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger.
NO20072352L (no) Forbindelser og sammensetninger som inhibitorer av cannabinoidreceptor 1-aktivitet
NO20043702L (no) 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
EE200300475A (et) Türosiini kinaasi inhibiitorid, neid sisaldavad ravimkoostised ja nimetatud ühendid kasutamiseks haiguste ravis
DK0966454T3 (da) Disubstituerede bicykliske heterocykler, deres fremstilling og deres anvendelse som lægemidler
IS2759B (is) CGRP-viðtakamótlyf, lyfjaefnablanda og notkun á efnablöndunum til framleiðslu á lyfi
UY28001A1 (es) Derivados de azol-pirimidina condensados
WO2001044239A3 (en) Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
WO2005009381A3 (en) Immediate-release formulation of acid-labile pharmaceutical compositions
UY28348A1 (es) Compuestos novedosos
CY1105247T1 (el) Υποκατεστημενα παραγωγα c- κυκλοεξυλομεθυλαμινης
IS8051A (is) Kladríbínefnablöndur til inngjafar um munn
NO20040268L (no) Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen
IL161582A0 (en) Use of oxindole hydrazide derivatives for the preparation of pharmaceutical compositions, certain such new derivatives and their preparation
DK1185253T3 (da) Oralt præparat til indgivelse af en fast kombination af tramadol og diclofenac
ECSP045493A (es) Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application